ATEC Quote, Financials, Valuation and Earnings

Retractable Technologies has a net margin of -26.29% compared to Alphatec Holdings's net margin of -18.58%. Alphatec Holdings's return on equity of -1019.24% beat Retractable Technologies's return on equity of -16.83%.

Alphatec Holdings has a consensus price target of $16.88, signalling upside risk potential of 80.68%. On the other hand Retractable Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Alphatec Holdings has higher upside potential than Retractable Technologies, analysts believe Alphatec Holdings is more attractive than Retractable Technologies.

Alphatec Holdings has a beta of 1.386, which suggesting that the stock is 38.566% more volatile than S&P 500. In comparison Retractable Technologies has a beta of 1.979, suggesting its more volatile than the S&P 500 by 97.877%.

Alphatec Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Retractable Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alphatec Holdings pays -- of its earnings as a dividend. Retractable Technologies pays out -3.32% of its earnings as a dividend.

Alphatec Holdings quarterly revenues are $150.7M, which are larger than Retractable Technologies quarterly revenues of $10.3M. Alphatec Holdings's net income of -$39.6M is lower than Retractable Technologies's net income of -$1.9M. Notably, Alphatec Holdings's price-to-earnings ratio is -- while Retractable Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alphatec Holdings is 2.29x versus 0.50x for Retractable Technologies. Usually stocks with elevated PS ratios are considered overvalued.

Tenon Medical has a net margin of -26.29% compared to Alphatec Holdings's net margin of -358.96%. Alphatec Holdings's return on equity of -1019.24% beat Tenon Medical's return on equity of -430.31%.

Alphatec Holdings has a consensus price target of $16.88, signalling upside risk potential of 80.68%. On the other hand Tenon Medical has an analysts' consensus of -- which suggests that it could grow by 332.43%. Given that Tenon Medical has higher upside potential than Alphatec Holdings, analysts believe Tenon Medical is more attractive than Alphatec Holdings.

Alphatec Holdings has a beta of 1.386, which suggesting that the stock is 38.566% more volatile than S&P 500. In comparison Tenon Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Alphatec Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tenon Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alphatec Holdings pays -- of its earnings as a dividend. Tenon Medical pays out -- of its earnings as a dividend.

Alphatec Holdings quarterly revenues are $150.7M, which are larger than Tenon Medical quarterly revenues of $887K. Alphatec Holdings's net income of -$39.6M is lower than Tenon Medical's net income of -$3.2M. Notably, Alphatec Holdings's price-to-earnings ratio is -- while Tenon Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alphatec Holdings is 2.29x versus 0.18x for Tenon Medical. Usually stocks with elevated PS ratios are considered overvalued.

Catheter Precision has a net margin of -26.29% compared to Alphatec Holdings's net margin of -4291.67%. Alphatec Holdings's return on equity of -1019.24% beat Catheter Precision's return on equity of -65.84%.

Alphatec Holdings has a consensus price target of $16.88, signalling upside risk potential of 80.68%. On the other hand Catheter Precision has an analysts' consensus of -- which suggests that it could grow by 506.06%. Given that Catheter Precision has higher upside potential than Alphatec Holdings, analysts believe Catheter Precision is more attractive than Alphatec Holdings.

Alphatec Holdings has a beta of 1.386, which suggesting that the stock is 38.566% more volatile than S&P 500. In comparison Catheter Precision has a beta of -0.210, suggesting its less volatile than the S&P 500 by 121.025%.

Alphatec Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alphatec Holdings pays -- of its earnings as a dividend. Catheter Precision pays out -- of its earnings as a dividend.

Alphatec Holdings quarterly revenues are $150.7M, which are larger than Catheter Precision quarterly revenues of $96K. Alphatec Holdings's net income of -$39.6M is lower than Catheter Precision's net income of -$4.1M. Notably, Alphatec Holdings's price-to-earnings ratio is -- while Catheter Precision's PE ratio is 0.38x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alphatec Holdings is 2.29x versus 0.88x for Catheter Precision. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings has a net margin of -26.29% compared to Alphatec Holdings's net margin of -17.98%. Alphatec Holdings's return on equity of -1019.24% beat Xtant Medical Holdings's return on equity of -35.98%.

Alphatec Holdings has a consensus price target of $16.88, signalling upside risk potential of 80.68%. On the other hand Xtant Medical Holdings has an analysts' consensus of -- which suggests that it could grow by 525%. Given that Xtant Medical Holdings has higher upside potential than Alphatec Holdings, analysts believe Xtant Medical Holdings is more attractive than Alphatec Holdings.

Alphatec Holdings has a beta of 1.386, which suggesting that the stock is 38.566% more volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of 0.357, suggesting its less volatile than the S&P 500 by 64.342%.

Alphatec Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alphatec Holdings pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

Alphatec Holdings quarterly revenues are $150.7M, which are larger than Xtant Medical Holdings quarterly revenues of $27.9M. Alphatec Holdings's net income of -$39.6M is lower than Xtant Medical Holdings's net income of -$5M. Notably, Alphatec Holdings's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alphatec Holdings is 2.29x versus 0.42x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.